164 related articles for article (PubMed ID: 17926107)
1. Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
Sahin A; Kiratli H; Soylemezoglu F; Tezel GG; Bilgic S; Saracbasi O
Jpn J Ophthalmol; 2007; 51(5):325-331. PubMed ID: 17926107
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
3. CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.
Lüke J; Vukoja V; Brandenbusch T; Nassar K; Rohrbach JM; Grisanti S; Lüke M; Tura A
BMC Ophthalmol; 2016 Jun; 16():74. PubMed ID: 27255356
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.
Sheidow TG; Hooper PL; Crukley C; Young J; Heathcote JG
Br J Ophthalmol; 2000 Jul; 84(7):750-6. PubMed ID: 10873988
[TBL] [Abstract][Full Text] [Related]
5. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
7. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.
Boyd SR; Tan D; Bunce C; Gittos A; Neale MH; Hungerford JL; Charnock-Jones S; Cree IA
Br J Ophthalmol; 2002 Apr; 86(4):448-52. PubMed ID: 11914216
[TBL] [Abstract][Full Text] [Related]
10. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma.
Mouriaux F; Sanschagrin F; Diorio C; Landreville S; Comoz F; Petit E; Bernaudin M; Rousseau AP; Bergeron D; Morcos M
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1277-83. PubMed ID: 24481264
[TBL] [Abstract][Full Text] [Related]
11. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG
Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496
[TBL] [Abstract][Full Text] [Related]
12. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
13. Expression and clinical significance of pepsinogen C in uveal melanomas.
Alvarez ML; González LO; Barbón JJ; Astudillo A; Vizoso FJ
Int J Biol Markers; 2004; 19(3):240-4. PubMed ID: 15503827
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor in uveal melanoma is independent of 6p21-region copy number.
Abdel-Rahman MH; Craig EL; Davidorf FH; Eng C
Clin Cancer Res; 2005 Jan; 11(1):73-8. PubMed ID: 15671530
[TBL] [Abstract][Full Text] [Related]
15. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
Alyahya GA
Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
[TBL] [Abstract][Full Text] [Related]
16. Novel mouse model for primary uveal melanoma: a pilot study.
Süsskind D; Hurst J; Rohrbach JM; Schnichels S
Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
Greco IM; Calvisi G; Ventura L; Cerrito F
Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
[TBL] [Abstract][Full Text] [Related]
18. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA
Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor a in eyes with uveal melanoma.
Missotten GS; Notting IC; Schlingemann RO; Zijlmans HJ; Lau C; Eilers PH; Keunen JE; Jager MJ
Arch Ophthalmol; 2006 Oct; 124(10):1428-34. PubMed ID: 17030710
[TBL] [Abstract][Full Text] [Related]
20. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
Pe'er J; Gnessin H; Shargal Y; Livni N
Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
